Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma (Q47415758)

15 January 2018

title

Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma (English)

1 reference

https://api.crossref.org/works/10.1016/S1072-7515(03)00750-6

26 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1072-7515(03)00750-6

26 March 2024

author name string

Baburao Koneru

2

1 reference

15 January 2018

Phil Baramipour

3

1 reference

15 January 2018

Adrian Fisher

4

1 reference

15 January 2018

Alison Barone

5

1 reference

15 January 2018

Dorian Wilson

6

1 reference

15 January 2018

Andrew Dela Torre

7

1 reference

15 January 2018

Daniel Contractor

9

1 reference

15 January 2018

Maria Korogodsky

10

1 reference

15 January 2018

Lawrence E. Harrison

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585410

26 March 2024

Kyunghee C. Cho

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585410

26 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14585410

26 March 2024

publication date

1 November 2003

1 reference

15 January 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S1072751503007506?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1072-7515(03)00750-6

https://api.elsevier.com/content/article/PII:S1072751503007506?httpAccept=text/plain

26 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1072-7515(03)00750-6

Journal of the American College of Surgeons

26 March 2024

published in

1 reference

15 January 2018

volume

197

1 reference

15 January 2018

issue

5

1 reference

15 January 2018

page(s)

759-764

1 reference

15 January 2018

Rising incidence of hepatocellular carcinoma in the United States

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900750-6

7 January 2021

Epidemiology of primary liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900750-6

7 January 2021

Increase in primary liver cancer in the UK, 1979-94

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900750-6

7 January 2021

Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900750-6

7 January 2021

Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900750-6

7 January 2021

Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900750-6

7 January 2021

Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900750-6

7 January 2021

Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900750-6

7 January 2021

Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900750-6

7 January 2021

Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900750-6

7 January 2021

Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900750-6

7 January 2021

Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900750-6

7 January 2021

Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a 'cooled-tip needle'. A preliminary clinical experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900750-6

7 January 2021

Local, intrahepatic, and systemic recurrence patterns after radiofrequency ablation of hepatic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900750-6

7 January 2021

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900750-6

7 January 2021

Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900750-6

7 January 2021

Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900750-6

7 January 2021

Prognostic factors for survival in hepatocellular carcinoma

7

1 reference

https://api.crossref.org/works/10.1016/S1072-7515(03)00750-6

26 March 2024

Identifiers

1 reference

15 January 2018

1 reference

15 January 2018